A randomized, double-blind study of triple nucleoside therapy of abacavir, lamivudine, and zidovudine versus lamivudine and zidovudine in previously treated human immunodeficiency virus type 1-infected children. The CNAA3006 Study Team.

Pediatrics

Volumn 107, Issue 1, 2001, Pages

  Saez Llorens X ^a   Nelson Jr , R P ^a   Emmanuel, P ^a   Wiznia, A ^a   Mitchell, C ^a   Church, J A ^a   Sleasman, J ^a   Van Dyke, R ^a   Richardson, C G ^a   Cutrell, A ^a   Spreen, W ^a   Hetherington, S ^a  

^a Hospital del Niño   (Panama)

Author keywords

[No Author keywords available]

Indexed keywords

2',3' DIDEOXYNUCLEOSIDE DERIVATIVE; ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; LAMIVUDINE; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; FEMALE; GENETICS; GROWTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INFANT; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; DIDEOXYNUCLEOSIDES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GROWTH; HIV-1; HUMANS; INFANT; LAMIVUDINE; MALE; RNA, VIRAL; ZIDOVUDINE;

EID: 0035228238     PISSN: None     EISSN: 10984275     Source Type: Journal    
DOI: None     Document Type: Article

References (0)